Offer - Urjas Oil for just ₹ 1 X
Tri Olvance 20 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Secondary and off-label uses of Tri Olvance 20 Tablet have also been mentioned below.
The optimal dosage of Tri Olvance 20 Tablet is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Tri Olvance 20 Tablet also has some side effects, the most common being Upper respiratory tract infection. Apart from the aforementioned side effects, Tri Olvance 20 Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Tri Olvance 20 Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Tri Olvance 20 Tablet's effect is Safe during pregnancy and Safe for lactating mothers. Further, the section on Tri Olvance 20 Tablet related warnings talks about Tri Olvance 20 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) must refrain from the use of Tri Olvance 20 Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Tri Olvance 20 Tablet contraindications section.
Drug interactions for Tri Olvance 20 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Tri Olvance 20 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Tri Olvance 20 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Tri Olvance 20 Tablet safe for pregnant women?
Tri Olvance is safe for pregnant women.
Is the use of Tri Olvance 20 Tablet safe during breastfeeding?
Tri Olvance is safe for breastfeeding women.
What is the effect of Tri Olvance 20 Tablet on the Kidneys?
Tri Olvance has very mild side effects on the kidneys.
What is the effect of Tri Olvance 20 Tablet on the Liver?
Very few cases of side effects of Tri Olvance on the liver have been reported.
What is the effect of Tri Olvance 20 Tablet on the Heart?
Very few cases of side effects of Tri Olvance on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Tri Olvance 20 Tablet unless your doctor advises you to do so -
Is this Tri Olvance 20 Tablet habit forming or addictive?
Tri Olvance 20 Tablet is not addictive in nature.
Interaction between Food and Tri Olvance 20 Tablet
When consumed with certain foods, Tri Olvance 20 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Tri Olvance 20 Tablet
Consuming Tri Olvance 20 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448